SLC5A2 and type 2 diabetes mellitus: The tubuloglomerular feedback system has been mainly used for the explanation for the desirable effects; however, from this review, the tubuloglomerular feedback system may not be a good explanation for the desirable effects of SGLT2 inhibitors on the heart and kidney in T2DM patients.